Trial Profile
Effects of Conversion to Belatacept After Kidney Transplantation on Immunophenotype of CD4+ T-cells
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 20 Aug 2015 New trial record